Ensign Peak Advisors’s Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares FLAC Stock Holding History

Ensign Peak Advisors’s Portfolio FLAC Stock Details FLAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-355,000	Closed	-$3.54M	–	2334
2022 Q3	$3.54M	Buy	355,000 +105,000	+42%	+$1.04M	0.01%	617
2022 Q2	$2.47M	Sell	250,000 -200,000	-44%	-$1.97M	0.01%	731
2022 Q1	$4.42M	Hold	450,000	–	–	0.01%	622
2021 Q4	$4.39M	Buy	+450,000	New	+$4.41M	0.01%	706

Ensign Peak Advisors's FLAC Position: Q4 2022 in Review

Ensign Peak Advisors sold out of Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares (FLAC) in Q4 2022, closing a stake of 355,000 shares — an estimated $3.54M sold.

Ensign Peak Advisors first reported a position in FLAC in Q4 2021 and held it in 4 quarters. The position peaked at $4.42M in Q1 2022. 0 funds tracked by Wall St. Rank hold FLAC as of Q4 2022.

Ensign Peak Advisors reported no remaining Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares position as of Q4 2022 after selling out during the quarter.
Ensign Peak Advisors sold 355,000 Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares shares in Q4 2022, an estimated $3.54M.
Ensign Peak Advisors first reported a position in Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares in Q4 2021 and held it in 4 quarters.
Ensign Peak Advisors's Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares position peaked at $4.42M in Q1 2022.
0 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares as of Q4 2022.

Based on Ensign Peak Advisors's 13F filing for Q4 2022, filed 13 Feb 2023.